[go: up one dir, main page]

AR057474A1 - Composiciones de donepezil gelificado y metodos para la fabricacion y utilizacion de las mismas - Google Patents

Composiciones de donepezil gelificado y metodos para la fabricacion y utilizacion de las mismas

Info

Publication number
AR057474A1
AR057474A1 ARP060103130A ARP060103130A AR057474A1 AR 057474 A1 AR057474 A1 AR 057474A1 AR P060103130 A ARP060103130 A AR P060103130A AR P060103130 A ARP060103130 A AR P060103130A AR 057474 A1 AR057474 A1 AR 057474A1
Authority
AR
Argentina
Prior art keywords
compositions
donepezil
manufacture
methods
gelified
Prior art date
Application number
ARP060103130A
Other languages
English (en)
Original Assignee
Teikoku Pharma Usa Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37727633&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR057474(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Teikoku Pharma Usa Inc filed Critical Teikoku Pharma Usa Inc
Publication of AR057474A1 publication Critical patent/AR057474A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Composiciones de donepezil gelificado y los métodos para fabricar y utilizar las mismas. Las composiciones incluyen un agente activo de donepezil en un vehículo oral gelificado farmacéuticamente aceptables que contienen una emulsion de agua y aceite. También se proporcionan kits de las composiciones.
ARP060103130A 2005-07-28 2006-07-20 Composiciones de donepezil gelificado y metodos para la fabricacion y utilizacion de las mismas AR057474A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US70410405P 2005-07-28 2005-07-28

Publications (1)

Publication Number Publication Date
AR057474A1 true AR057474A1 (es) 2007-12-05

Family

ID=37727633

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP060103130A AR057474A1 (es) 2005-07-28 2006-07-20 Composiciones de donepezil gelificado y metodos para la fabricacion y utilizacion de las mismas

Country Status (6)

Country Link
US (1) US20070026075A1 (es)
EP (1) EP1906925A1 (es)
JP (1) JP2009502917A (es)
AR (1) AR057474A1 (es)
TW (1) TW200726468A (es)
WO (1) WO2007018801A1 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0818473D0 (en) 2008-10-08 2008-11-12 Probio Nutraceuticals As Composition
WO2010113325A1 (ja) * 2009-04-03 2010-10-07 日医工ファーマ株式会社 ペクチン含有ゼリー製剤
US9125809B2 (en) * 2009-04-03 2015-09-08 Nichi-Iko Pharmaceutical Co., Ltd. Pectin-containing jelly formulation
GB201006182D0 (en) * 2010-04-14 2010-06-02 Ayanda As Composition
GB201006178D0 (en) * 2010-04-14 2010-06-02 Ayanda As Composition
GB201006218D0 (en) 2010-04-14 2010-06-02 Ayanda As Composition
US9132291B2 (en) 2010-10-05 2015-09-15 Dfb Technology, Ltd. Water-in-oil emulsion compositions containing gellan gum for topical delivery of active ingredients to the skin or mucosa
GB201016900D0 (en) * 2010-10-06 2010-11-17 Probio Asa Emulsion
JP2012188383A (ja) * 2011-03-10 2012-10-04 Towa Yakuhin Kk ドネペジル塩酸塩の内用液剤
US10994013B2 (en) 2013-04-24 2021-05-04 Temple University—Of the Commonwealth System of Higher Education Solid dosage form containing arabinogalactan
KR102142026B1 (ko) * 2017-05-31 2020-08-06 주식회사 대웅제약 방출제어가 용이한 서방성 약물 미립자의 제조방법
CN114246824B (zh) * 2022-01-24 2023-08-22 南京康川济医药科技有限公司 一种多奈哌齐口服凝胶及其制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI95572C (fi) * 1987-06-22 1996-02-26 Eisai Co Ltd Menetelmä lääkeaineena käyttökelpoisen piperidiinijohdannaisten tai sen farmaseuttisen suolan valmistamiseksi
WO1997025024A1 (en) * 1996-01-12 1997-07-17 Ohta Pharmaceutical Co., Ltd. Jellied medicinal composition for oral administration
TW513409B (en) * 1996-06-07 2002-12-11 Eisai Co Ltd Polymorphs of donepezil hydrochloride
AU1153097A (en) * 1996-06-07 1998-01-05 Eisai Co. Ltd. Stable polymorphs of donepezil (1-benzyl-4-{(5,6-dimethoxy-1-indanon)-2-yl}methylpiperidine ) hydrochloride and process for production
US6245911B1 (en) * 1997-12-05 2001-06-12 Eisai Co., Ltd. Donepezil polycrystals and process for producing the same
ES2237078T3 (es) * 1998-01-16 2005-07-16 Eisai Co., Ltd. Procedimiento para producir derivados de donepezilo.
US6193993B1 (en) * 1998-03-03 2001-02-27 Eisai Co., Ltd. Suppository containing an antidementia medicament
US6576677B1 (en) * 1998-08-28 2003-06-10 Eisai Co., Ltd. Medicinal compositions with relieved bitterness
US20060183776A9 (en) * 2000-03-03 2006-08-17 Eisai Co., Ltd. Liquid dosage formulations of donepezil
IL150509A (en) * 2002-07-01 2007-07-04 Joseph Kaspi Pharmaceutical preparations containing donafazil hydrochloride
US20050004104A1 (en) * 2003-05-30 2005-01-06 Cali Brian M. Methods for the protection of memory and cognition
WO2005065308A2 (en) * 2003-12-29 2005-07-21 Jason Mcdevitt Compositions and methods to treat recurrent medical conditions

Also Published As

Publication number Publication date
US20070026075A1 (en) 2007-02-01
JP2009502917A (ja) 2009-01-29
TW200726468A (en) 2007-07-16
EP1906925A1 (en) 2008-04-09
WO2007018801A1 (en) 2007-02-15

Similar Documents

Publication Publication Date Title
UY28285A1 (es) Péliculas consumibles por vía oral que se disuelven rápidamente, que contienen un edulcorante
CL2004000931A1 (es) Pelicula consumible adaptada para adherirse y disolverse en la cavidad bucal que comprende un almidon modificado y un agente farmaceuticamente activo.
GT200600474A (es) Composiciones farmaceuticas solidas que contienen pregabalina
AR057474A1 (es) Composiciones de donepezil gelificado y metodos para la fabricacion y utilizacion de las mismas
PE20110010A1 (es) Formulaciones liquidas de fenilefrina
UY28215A1 (es) Quinazolinas utiles como moduladores de canales iónicos
HN2004000490A (es) Procedimiento para la preparacion de una composicion farmaceutica solida administrable oralmente
UY30327A1 (es) Nuevos compuestos ii
AR061772A1 (es) Composicion de alto contenido de ion fluoruro para el cuidado oral y metodo para mantener la actividad anticaries
ES2167061T3 (es) Formas de dosificacion para mejorar la disfuncion erectil en pacientes de sexo masculino.
UY31456A1 (es) Derivados de 2-pirazinona como inhibidores de la elastasa de los neutrofilos
CL2008002407A1 (es) Forma de dosificacion oral que comprende al menos un agente activo de nicotina, al menos un material bioadhesivo capaz de formar un enlace de hidrogeno con el agente activo de nicotina, y al menos un agente de impacto sensorial que se libere rapidamente; y su uso para proporcionar alivio rapido de las ansias de nicotina (div. sol. 1825-04).
MXPA05007643A (es) Metodo para producir una forma farmaceutica oral con desintegracion inmediata y liberacion de ingrediente activo.
PE20100254A1 (es) Forma de dosificacion farmaceutica en capsula que comprende una formulacion en suspension de un derivado de indolinona
AR043150A1 (es) Composicion oral que contiene enzimas con estabilidad mejorada
CR9587A (es) Derivados de piridazina
PA8625001A1 (es) Composiciones de pelicula
AR055552A1 (es) Preparacion topica refrescante para parches y metodos para utilizar la misma
HN2006035237A (es) Derivados de triazolopiridina en calidad de inhibidores de lipasas y fosfolipasas
MXPA05012319A (es) Suministro de compuestos con celulas sanguineas rehidratadas.
EA200901393A1 (ru) Фармацевтическая композиция, содержащая гестагены и/или эстрогены и 5 метил-(6s)-тетрагидрофолат
PA8586301A1 (es) Formulaciones de liberacion prolongada en forma de suspension
AR063027A1 (es) Derivados de sulfonamida
AR056500A1 (es) Metodo para preparar una composicion medica
AR065068A1 (es) Composicion farmaceutica que comprende tramadol y ketoprofeno en asociacion

Legal Events

Date Code Title Description
FA Abandonment or withdrawal